KLSE:HSPLANT Statistics
Total Valuation
KLSE:HSPLANT has a market cap or net worth of MYR 1.72 billion. The enterprise value is 999.58 million.
Important Dates
The next estimated earnings date is Tuesday, February 23, 2027.
| Earnings Date | Feb 23, 2027 |
| Ex-Dividend Date | Sep 9, 2026 |
Share Statistics
KLSE:HSPLANT has 799.69 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 799.69M |
| Shares Outstanding | 799.69M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 0.99% |
| Owned by Institutions (%) | 11.94% |
| Float | 211.54M |
Valuation Ratios
The trailing PE ratio is 13.38 and the forward PE ratio is 9.92. KLSE:HSPLANT's PEG ratio is 0.83.
| PE Ratio | 13.38 |
| Forward PE | 9.92 |
| PS Ratio | 2.28 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | 8.57 |
| P/OCF Ratio | 6.13 |
| PEG Ratio | 0.83 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 3.81, with an EV/FCF ratio of 4.98.
| EV / Earnings | 7.78 |
| EV / Sales | 1.33 |
| EV / EBITDA | 3.81 |
| EV / EBIT | 5.87 |
| EV / FCF | 4.98 |
Financial Position
The company has a current ratio of 9.79, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.79 |
| Quick Ratio | 8.46 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 0.34 |
| Interest Coverage | 49.26 |
Financial Efficiency
Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 8.89%.
| Return on Equity (ROE) | 6.03% |
| Return on Assets (ROA) | 4.87% |
| Return on Invested Capital (ROIC) | 8.89% |
| Return on Capital Employed (ROCE) | 6.61% |
| Weighted Average Cost of Capital (WACC) | 3.38% |
| Revenue Per Employee | 94,520 |
| Profits Per Employee | 16,122 |
| Employee Count | 7,968 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 4.09 |
Taxes
In the past 12 months, KLSE:HSPLANT has paid 38.46 million in taxes.
| Income Tax | 38.46M |
| Effective Tax Rate | 23.04% |
Stock Price Statistics
The stock price has decreased by -2.71% in the last 52 weeks. The beta is -0.16, so KLSE:HSPLANT's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -2.71% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 2.31 |
| Relative Strength Index (RSI) | 33.21 |
| Average Volume (20 Days) | 290,600 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:HSPLANT had revenue of MYR 753.13 million and earned 128.46 million in profits. Earnings per share was 0.16.
| Revenue | 753.13M |
| Gross Profit | 297.83M |
| Operating Income | 170.37M |
| Pretax Income | 166.92M |
| Net Income | 128.46M |
| EBITDA | 235.20M |
| EBIT | 170.37M |
| Earnings Per Share (EPS) | 0.16 |
Full Income Statement Balance Sheet
The company has 788.15 million in cash and 68.41 million in debt, with a net cash position of 719.74 million or 0.90 per share.
| Cash & Cash Equivalents | 788.15M |
| Total Debt | 68.41M |
| Net Cash | 719.74M |
| Net Cash Per Share | 0.90 |
| Equity (Book Value) | 2.16B |
| Book Value Per Share | 2.70 |
| Working Capital | 840.87M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 280.70 million and capital expenditures -80.13 million, giving a free cash flow of 200.57 million.
| Operating Cash Flow | 280.70M |
| Capital Expenditures | -80.13M |
| Depreciation & Amortization | 64.83M |
| Net Borrowing | -13.75M |
| Free Cash Flow | 200.57M |
| FCF Per Share | 0.25 |
Full Cash Flow Statement Margins
Gross margin is 39.55%, with operating and profit margins of 22.62% and 17.06%.
| Gross Margin | 39.55% |
| Operating Margin | 22.62% |
| Pretax Margin | 22.16% |
| Profit Margin | 17.06% |
| EBITDA Margin | 31.23% |
| EBIT Margin | 22.62% |
| FCF Margin | 26.63% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 3.54%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 3.54% |
| Dividend Growth (YoY) | -35.20% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 50.43% |
| FCF Payout Ratio | 32.30% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 3.54% |
| Earnings Yield | 7.47% |
| FCF Yield | 11.67% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for KLSE:HSPLANT is 3.07, which is 42.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 3.07 |
| Price Target Difference | 42.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 6.41% |
| EPS Growth Forecast (3Y) | 7.93% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |